Advanced systemic mastocytosis
Showing 1 - 25 of >10,000
Advanced Systemic Mastocytosis Trial (BLU-263, Azacitidine)
Not yet recruiting
- Advanced Systemic Mastocytosis
- (no location specified)
Nov 2, 2022
Aggressive Systemic Mastocytosis, Systemic Mastocytosis-associated Hematologic Non-mast Cell Disease, Mast Cell Leukemia Trial
Completed
- Aggressive Systemic Mastocytosis
- +3 more
-
Stanford, California
- +10 more
Jan 12, 2023
Advanced Systemic Mastocytosis (AdvSM), SM With an Associated Hematologic Tumor (SM-AHN), Mast Cell Leukemia (MCL) Trial in
Recruiting
- Advanced Systemic Mastocytosis (AdvSM)
- +3 more
- CGT9486 tablets
-
Duarte, California
- +10 more
Jul 8, 2022
Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Systemic Mastocytosis With an Associated Hematological Tumor
Approved for marketing
- Advanced Systemic Mastocytosis
- +3 more
- (no location specified)
Oct 5, 2021
Avapritinib Versus Best Available Therapy in Patients With AdvSM
Completed
- Advanced Systemic Mastocytosis
- +3 more
-
Palo Alto, California
- +5 more
Dec 17, 2021
High-risk MDS, Acute Myelogenous Leukemia, Systemic Mastocytosis Trial in Minneapolis, Madison (GTB-3550 TriKE® Phase I,
Terminated
- High-risk Myelodysplastic Syndromes
- +3 more
- GTB-3550 TriKE® Phase I
- GTB-3550 TriKE® Phase II
-
Minneapolis, Minnesota
- +1 more
Mar 21, 2022
Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Systemic Mastocytosis With an Associated Hematologic Tumor
Active, not recruiting
- Advanced Systemic Mastocytosis
- +3 more
-
Stanford, California
- +31 more
Mar 25, 2022
A Registry for Patients With Systemic Mastocytosis in China
Not yet recruiting
- Systemic Mastocytoses
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University, Jiangsu Ins
Aug 24, 2023
Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Tumor Trial in
Recruiting
- Recurrent Acute Leukemia
- +16 more
- Acetaminophen
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 22, 2022
Quality of Life and Disease-related Symptoms in Individuals With
Not yet recruiting
- Mastocytosis, Systemic
- No intervention
-
Stockholm, Sweden
- +1 more
Sep 26, 2023
DALY on a Cohort of Patients With Indolent Systemic Mastocytosis
Recruiting
- Mastocytosis, Indolent Systemic
-
Toulouse, Haute-Garonne, FranceCentre de Référence des Mastocytoses, Service de Dermatologie, H
Jun 19, 2023
Gastrointestinal Stromal Tumors, Advanced Systemic Mastocytosis, Advanced Cancers Trial in Worldwide (DCC-2618)
Active, not recruiting
- Gastrointestinal Stromal Tumors
- +2 more
-
Scottsdale, Arizona
- +25 more
Apr 16, 2021
Myelofibrosis, Chronic Myelomonocytic Leukemia Trial in Canada, United States (SL-401)
Active, not recruiting
- Myelofibrosis
- Chronic Myelomonocytic Leukemia
-
Duarte, California
- +9 more
Jan 24, 2023
Systemic Mastocytosis With AHNMD, Acute Myeloid Leukemia With T(8;21)(Q22;Q22) Trial in Suzhou
Not yet recruiting
- Systemic Mastocytosis With AHNMD
- Acute Myeloid Leukemia With T(8;21)(Q22;Q22)
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University, Jiangsu Ins
Aug 16, 2022
SSM, Mastocytosis, Indolent, Mastocytosis, Systemic Trial in United States (CGT9486 Tablets, Placebo Tablets)
Recruiting
- SSM
- +3 more
- CGT9486 Tablets
- Placebo Tablets
-
Clearwater, Florida
- +5 more
Apr 14, 2022
Mastocytosis Trial in Toulouse (Hydroxychloroquine)
Not yet recruiting
- Mastocytosis
-
Toulouse, FranceLarrey Hospital - Toulouse University Hospital
Oct 6, 2021
Indolent Systemic Mastocytosis Trial in France, Germany, United States (Masitinib, Placebo, Best Supportive Care)
Recruiting
- Indolent Systemic Mastocytosis
- Masitinib
- +2 more
-
Rochester, Minnesota
- +6 more
Nov 29, 2021
Pregnancy and Medically Assisted Conception in Rare Diseases
Recruiting
- Rheumatoid Arthritis
- +10 more
-
Paris, FranceHôpital Cochin
Oct 31, 2022
Osteoporosis, Systemic Mastocytosis Trial in France (Denosumab, Placebo)
Active, not recruiting
- Osteoporosis
- Systemic Mastocytosis
- Denosumab
- Placebo
-
Besançon, France
- +10 more
Apr 13, 2021
Indolent Systemic Mastocytosis, Monoclonal Mast Cell Activation Syndrome Trial in Worldwide (BLU-263, Placebo)
Recruiting
- Indolent Systemic Mastocytosis
- Monoclonal Mast Cell Activation Syndrome
- BLU-263
- Placebo
-
Palo Alto, California
- +33 more
Jul 27, 2022
Advanced Hepatocellular Carcinoma That Has Failed at Systemic Therapy Trial in Tianjin (Cadonilimab Injection, Ramucirumab
Recruiting
- Advanced Hepatocellular Carcinoma That Has Failed at Systemic Therapy
- Cadonilimab Injection
- Ramucirumab Injection
-
Tianjin, Tianjin, ChinaTianjin Cancer Hospital Airport Hospital
May 14, 2023
CT Perfusion Parameters for Advanced HCC Treated by Systemic
Completed
- Advanced HCC Treated by Systemic Immunotherapy
-
Nancy, FranceCHRU Nancy
Oct 13, 2022
Myocardial Infarction Trial in Charlottesville (Dapansutrile, Placebo)
Not yet recruiting
- Myocardial Infarction
- Dapansutrile
- Placebo
-
Charlottesville, VirginiaUniversity of Virginia
May 19, 2023
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1
Not yet recruiting
- Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
- Ivosidenib 500mg
- Placebo
- (no location specified)
Nov 7, 2023
